Thats why the FDAs own technical staff has recommended against expanded access, and the public health group Partnership for Safe Medicines calls them "popular, unproven, dangerous. As Peter Kolchinsky, managing partner of biotech investor RA Capital Management, puts it: Is the FDA going to stand on science or is it going to permit all kinds of snake oil to be readily available? The FDA meeting will last two days
However, both come with serious health and legal risks
One of the most exciting applications of peptide therapy is in the realm of weight loss, where a peptide known as GLP-1 Injections is making a significant impact
This route remains less studied than injection or oral administration for penta deca peptide arginate specifically, but the anatomical advantages are well-established for peptide delivery in general
Comment: Several commenters encouraged CMS to incorporate robust risk adjustment to account for patient case mix and volumes and the availability of post-acute care services within a hospital's service area